BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22950410)

  • 1. Common inversion polymorphism at 17q21.31 affects expression of multiple genes in tissue-specific manner.
    de Jong S; Chepelev I; Janson E; Strengman E; van den Berg LH; Veldink JH; Ophoff RA
    BMC Genomics; 2012 Sep; 13():458. PubMed ID: 22950410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent inversion events at 17q21.31 microdeletion locus are linked to the MAPT H2 haplotype.
    Rao PN; Li W; Vissers LE; Veltman JA; Ophoff RA
    Cytogenet Genome Res; 2010; 129(4):275-9. PubMed ID: 20606400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different MAPT haplotypes are associated with Parkinson's disease and progressive supranuclear palsy.
    Ezquerra M; Pastor P; Gaig C; Vidal-Taboada JM; Cruchaga C; Muñoz E; Martí MJ; Valldeoriola F; Aguilar M; Calopa M; Hernandez-Vara J; Tolosa E
    Neurobiol Aging; 2011 Mar; 32(3):547.e11-6. PubMed ID: 19879020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration.
    Pittman AM; Myers AJ; Abou-Sleiman P; Fung HC; Kaleem M; Marlowe L; Duckworth J; Leung D; Williams D; Kilford L; Thomas N; Morris CM; Dickson D; Wood NW; Hardy J; Lees AJ; de Silva R
    J Med Genet; 2005 Nov; 42(11):837-46. PubMed ID: 15792962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structure of the tau haplotype in controls and in progressive supranuclear palsy.
    Pittman AM; Myers AJ; Duckworth J; Bryden L; Hanson M; Abou-Sleiman P; Wood NW; Hardy J; Lees A; de Silva R
    Hum Mol Genet; 2004 Jun; 13(12):1267-74. PubMed ID: 15115761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening non-MAPT genes of the Chr17q21 H1 haplotype in Parkinson's disease.
    Soto-Beasley AI; Walton RL; Valentino RR; Hook PW; Labbé C; Heckman MG; Johnson PW; Goff LA; Uitti RJ; McLean PJ; Springer W; McCallion AS; Wszolek ZK; Ross OA
    Parkinsonism Relat Disord; 2020 Sep; 78():138-144. PubMed ID: 32829096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson's disease are associated with LRRC37A/2 expression in astrocytes.
    Bowles KR; Pugh DA; Liu Y; Patel T; Renton AE; Bandres-Ciga S; Gan-Or Z; Heutink P; Siitonen A; Bertelsen S; Cherry JD; Karch CM; Frucht SJ; Kopell BH; Peter I; Park YJ; ; Charney A; Raj T; Crary JF; Goate AM
    Mol Neurodegener; 2022 Jul; 17(1):48. PubMed ID: 35841044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unraveling the complex role of MAPT-containing H1 and H2 haplotypes in neurodegenerative diseases.
    Pedicone C; Weitzman SA; Renton AE; Goate AM
    Mol Neurodegener; 2024 May; 19(1):43. PubMed ID: 38812061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel haplotypes in 17q21 are associated with progressive supranuclear palsy.
    Pastor P; Ezquerra M; Perez JC; Chakraverty S; Norton J; Racette BA; McKeel D; Perlmutter JS; Tolosa E; Goate AM
    Ann Neurol; 2004 Aug; 56(2):249-58. PubMed ID: 15293277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5'-Upstream variants of CRHR1 and MAPT genes associated with age at onset in progressive supranuclear palsy and cortical basal degeneration.
    Cruchaga C; Vidal-Taboada JM; Ezquerra M; Lorenzo E; Martinez-Lage P; Blazquez M; Tolosa E; ; Pastor P
    Neurobiol Dis; 2009 Feb; 33(2):164-70. PubMed ID: 19022385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic architecture of human 17q21 linked to frontotemporal dementia uncovers a highly homologous family of low-copy repeats in the tau region.
    Cruts M; Rademakers R; Gijselinck I; van der Zee J; Dermaut B; de Pooter T; de Rijk P; Del-Favero J; van Broeckhoven C
    Hum Mol Genet; 2005 Jul; 14(13):1753-62. PubMed ID: 15888485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using the neanderthal and denisova genetic data to understand the common MAPT 17q21 inversion in modern humans.
    Setó-Salvia N; Sánchez-Quinto F; Carbonell E; Lorenzo C; Comas D; Clarimón J
    Hum Biol; 2012 Dec; 84(6):633-40. PubMed ID: 23959642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders.
    Lai MC; Bechy AL; Denk F; Collins E; Gavriliouk M; Zaugg JB; Ryan BJ; Wade-Martins R; Caffrey TM
    Mol Neurodegener; 2017 Oct; 12(1):79. PubMed ID: 29084565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the tau gene region chromosome inversion in progressive supranuclear palsy, corticobasal degeneration, and related disorders.
    Webb A; Miller B; Bonasera S; Boxer A; Karydas A; Wilhelmsen KC
    Arch Neurol; 2008 Nov; 65(11):1473-8. PubMed ID: 19001166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolutionary toggling of the MAPT 17q21.31 inversion region.
    Zody MC; Jiang Z; Fung HC; Antonacci F; Hillier LW; Cardone MF; Graves TA; Kidd JM; Cheng Z; Abouelleil A; Chen L; Wallis J; Glasscock J; Wilson RK; Reily AD; Duckworth J; Ventura M; Hardy J; Warren WC; Eichler EE
    Nat Genet; 2008 Sep; 40(9):1076-83. PubMed ID: 19165922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study.
    Tobin JE; Latourelle JC; Lew MF; Klein C; Suchowersky O; Shill HA; Golbe LI; Mark MH; Growdon JH; Wooten GF; Racette BA; Perlmutter JS; Watts R; Guttman M; Baker KB; Goldwurm S; Pezzoli G; Singer C; Saint-Hilaire MH; Hendricks AE; Williamson S; Nagle MW; Wilk JB; Massood T; Laramie JM; DeStefano AL; Litvan I; Nicholson G; Corbett A; Isaacson S; Burn DJ; Chinnery PF; Pramstaller PP; Sherman S; Al-hinti J; Drasby E; Nance M; Moller AT; Ostergaard K; Roxburgh R; Snow B; Slevin JT; Cambi F; Gusella JF; Myers RH
    Neurology; 2008 Jul; 71(1):28-34. PubMed ID: 18509094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue.
    Tauber CV; Schwarz SC; Rösler TW; Arzberger T; Gentleman S; Windl O; Krumbiegel M; Reis A; Ruf VC; Herms J; Höglinger GU
    Acta Neuropathol Commun; 2023 Mar; 11(1):40. PubMed ID: 36906636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease.
    Vandrovcova J; Pittman AM; Malzer E; Abou-Sleiman PM; Lees AJ; Wood NW; de Silva R
    Neurobiol Aging; 2009 Sep; 30(9):1477-82. PubMed ID: 18162161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From 1997 to 2007: a decade journey through the H1 haplotype on 17q21 chromosome.
    Kalinderi K; Fidani L; Bostantjopoulou S
    Parkinsonism Relat Disord; 2009 Jan; 15(1):2-5. PubMed ID: 18424220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haplotype-specific expression of exon 10 at the human MAPT locus.
    Caffrey TM; Joachim C; Paracchini S; Esiri MM; Wade-Martins R
    Hum Mol Genet; 2006 Dec; 15(24):3529-37. PubMed ID: 17085483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.